YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence
about
New frontiers in translational control of the cancer genomeInterplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells.Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction.Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer.Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations.The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression.A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer.
P2860
Q33853235-EAF2FCDA-FF04-4AB0-B18A-8D9C01FF88F5Q36546008-BDB6C7BD-8BC2-4A4F-9E4C-82361315D71CQ38706050-27EFDA04-A3C0-4359-B733-69EB1F790009Q38780013-33F6ADB5-02F2-4297-BC29-C88DD0EC2CE0Q46885929-97CBD7DB-86E0-4C99-973B-37EB552B47E2Q47112301-420F396E-EF57-465C-A7A8-6B86224A062CQ53704366-AFF9C701-0E41-4AF1-983D-3361ECF093A8
P2860
YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
YB-1 and MTA1 protein levels a ...... for prostate cancer recurrence
@ast
YB-1 and MTA1 protein levels a ...... for prostate cancer recurrence
@en
type
label
YB-1 and MTA1 protein levels a ...... for prostate cancer recurrence
@ast
YB-1 and MTA1 protein levels a ...... for prostate cancer recurrence
@en
prefLabel
YB-1 and MTA1 protein levels a ...... for prostate cancer recurrence
@ast
YB-1 and MTA1 protein levels a ...... for prostate cancer recurrence
@en
P2093
P2860
P356
P1433
P1476
YB-1 and MTA1 protein levels a ...... for prostate cancer recurrence
@en
P2093
Andrew C Hsieh
Christine Moore Sheridan
Davide Ruggero
Matthew B Rettig
Tristan R Grogan
P2860
P304
P356
10.18632/ONCOTARGET.3477
P407
P577
2015-04-01T00:00:00Z